Vassileva, S., Murrell, D. F. ., Culton, D. A. ., Ujiie, H., Hertl, M., Goebeler, M., Sinha, A. A., Schmidt, E., Stoykov, I., Verheesen, P., Borradori, L., Werth, V. P., & Joly, P. (2024). Overview of Clinical Trials With Efgartigimod in Autoimmune Blistering Diseases: Pemphigus Vulgaris and Pemphigus Foliaceus (ADDRESS and ADDRESS+) and Bullous Pemphigoid (BALLAD and BALLAD+). SKIN The Journal of Cutaneous Medicine, 8(1), s345. https://doi.org/10.25251/skin.8.supp.345